ChromaDex Corporation (NASDAQ:CDXC) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to ChromaDex Corporation's Second Quarter of 2024 Earnings Conference Call.
Chromadex Corp. (CDXC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | D E Shaw D. E. Shaw | 1,011,290 | $5,364,893 | +1786% | 0% |
| 2. | Renaissance Technologies Jim Simons | 712,788 | $3,781,340 | +69% | 0% |
| 3. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 662,956 | $3,516,982 | +289% | 0% |
| 4. | Millennium Management Israel Englander | 226,089 | $1,199,402 | 0% | |
| 5. | Tudor Investment Corp Paul Tudor Jones | 217,568 | $1,154,198 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.36 | 2,907 | Officer | 2,907 | 2024-11-22 | Filing | |
| $0.00 | 11,408,715 | 19,294,356 | 2024-08-20 | Filing | ||
| $1.41 | 5,000 | Officer | 27,436 | 2023-12-01 | Filing | |
| $0.00 | 3,467,778 | Large Shareholder, Director | 11,408,715 | 2023-09-06 | Filing | |
| $1.69 | 7,000 | Director | 231,339 | 2023-06-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.19 | 37,161 | Director | 244,179 | 2024-12-13 | Filing | |
| $3.57 | 23,000 | Director | 0 | 2024-08-23 | Filing | |
| $0.00 | 11,408,715 | 0 | 2024-08-20 | Filing | ||
| $13.17 | 20,000 | 16,667 | 2021-03-16 | Filing | ||
| $11.15 | 32,500 | 16,667 | 2021-03-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,611,585 | $19,159,458 | 0% | |
| 2. | 3,389,547 | $17,981,547 | 0% | |
| 3. | 1,296,354 | $6,883,640 | 0.1% | |
| 4. | 1,154,778 | $6,127,776 | 0% | |
| 5. | 914,975 | $4,853,942 | 0% |
News See All
ChromaDex Corporation (NASDAQ:CDXC) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. And welcome to ChromaDex Corporation's First Quarter of 2024 Earnings Conference Call.
ChromaDex Corporation (NASDAQ:CDXC) Q4 2023 Earnings Call Transcript
ChromaDex Corporation beats earnings expectations. Reported EPS is $0.00152, expectations were $-0.03.
ChromaDex Corporation (NASDAQ:CDXC) Q3 2023 Earnings Call Transcript
Operator: Hello and thank you for standing by. My name is Regina and I'll be your conference operator today.
ChromaDex Corporation (NASDAQ:CDXC) Q2 2023 Earnings Call Transcript
Operator: Hello. My name is Aisha and I'll be your conference operator today. At this time, I'd like to welcome everyone to the ChromaDex Second Quarter 2023 Conference Call. [Operator Instructions].
ChromaDex Corporation (NASDAQ:CDXC) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by and welcome to ChromaDex Corporation's First Quarter 2023 Earnings Conference Call.
ChromaDex Corporation (NASDAQ:CDXC) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to ChromaDex Corporation's Fourth Quarter 2022 Earnings Conference Call.
Is ChromaDex (CDXC) A Good Stock To Buy Now?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Here is What Hedge Funds Think About ChromaDex Corporation (CDXC)
In this article we will take a look at whether hedge funds think ChromaDex Corporation (NASDAQ:CDXC) is a good investment right now.
Hedge Funds Have Never Been More Bullish On ChromaDex Corporation (CDXC)
Investing in small cap stocks has historically been a way to outperform the market, as small cap companies typically grow faster on average than the blue chips.
Billionaire Hedge Funds
